ERBB2 and breast cancer: Based on the reported associations between NF-κB and HER2 overexpression in breast cancer, we investigated the effect of CLA on cell growth characteristics in the HER2 overexpressing SKBr3 breast cancer cells with the hypothesis that CLA would inhibit HER2 by downreguating NF-κB signaling.